Impact of the inpatient infectious disease consultations at a tertiary care university hospital
DOI:
https://doi.org/10.3823/844Keywords:
Infectious Disease specialist, Consultation services, Antibiotic stewardship, Antibiotic de-escalation, Impact Assessment, Inpatient treatmentAbstract
BACKGROUND: The role of the infectious disease specialist continues to evolve. The purpose of this study is to demonstrate the value of infectious disease consultation in the inpatient setting.
METHODS: This is a prospective cohort study that took place in a tertiary care university hospital. During the period from April to June 2016, 224 cases of patients receiving antibiotics in the hospital with the request of an infectious diseases’ consultation, were evaluated. The following variables were assessed: the referring department, purpose of the consultation, the antibiotic used before requesting the infectious diseases consultation, the antibiotic modifications after the infectious disease’s visit, whenever the antibiotic usage was switched to a mono or bi-therapy.
RESULTS: The most frequent requesting departments were Oncology (23.2%) and Urology (21.4%). The purpose of the consultations was diagnosis (29%), therapy (41%), both diagnosis and therapy (21%), and prophylaxis (9%). An infectious diseases consultation was given at a rate of 4.9 consultations per 100 hospitalized patients. Antibiotic was discontinued in 14.7% of cases. There was no indication for the antibiotic treatment in 11.6% of cases. Modifying the antibiotic therapy was done in 25.4% of cases. Adjusting the antibiotic dosage was done in only one case. Carbapenem antibiotics were discontinued in 31.6 % of cases and Quinolones discontinuation accounted for 22.7% of cases.
CONCLUSION: Infectious disease consults contributed to the optimization of the diagnostic and therapeutic approaches for suspected or confirmed infections in hospitalized patients.
References
Wernli D, Haustein T, Conly J, Carmeli Y, Kickbusch I, Harbarth
S. A Call for Action: The Application of the International Health
Regulations to the Global Threat of Antimicrobial Resistance.
PLoS Med [Internet]. 2011 Apr 19 [cited 2019 Aug 10];8(4).
Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC3079636/
WHO|Antimicrobial resistance: global report on surveillance
[Internet]. WHO. [cited 2019 Aug 10]. Available from: http://
www.who.int/drugresistance/documents/surveillancereport/en/
Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice
LB, et al. Bad bugs, no drugs: no ESKAPE! An update from the
Infectious Diseases Society of America. Clin Infect Dis Off Publ
Infect Dis Soc Am 2009;48(1):1–12.
Levy SB, Marshall B. Antibacterial resistance worldwide: causes,
challenges and responses. Nat Med 2004;10(12):S122-129.
Antimicrobial Resistance [Internet]. [cited 2019 Aug 10].
Available from: https://www.idsociety.org/policy--advocacy/
antimicrobial-resistance/
Schuts EC, Hulscher MEJL, Mouton JW, Verduin CM, Stuart
JWTC, Overdiek HWPM, et al. Current evidence on hospital
antimicrobial stewardship objectives: a systematic review and
meta-analysis. Lancet Infect Dis 2016;16(7):847–56.
Dik J-WH, Vemer P, Friedrich AW, Hendrix R, Lo-Ten-Foe JR,
Sinha B, et al. Financial evaluations of antibiotic stewardship
programs—a systematic review. Front Microbiol [Internet]. 2015
Apr 16 [cited 2020 Jun 14];6. Available from: https://www.ncbi.
nlm.nih.gov/pmc/articles/PMC4399335/
Eickhoff TC. Editorial. Whither Infectious Diseases? Some Data
at Last. J Infect Dis 1992;165(2):201–4.
Hamory BH, Hicks LL. Infectious disease manpower in the United
States-1986. 2. Changes in practice patterns over time and
training needs. Manpower and Training Committee, Infectious
Diseases Society of America. J Infect Dis 1992;165(2):218–23.
McGowan JE. The infection control practitioner: An action plan
for the 1990s. Am J Infect Control 1990;18(1):29–39.
Brink AJ, Messina AP, Feldman C, Richards GA, Becker PJ,
Goff DA, et al. Antimicrobial stewardship across 47 South
African hospitals: an implementation study. Lancet Infect Dis.
;16(9):1017–25.
Boyles TH, Whitelaw A, Bamford C, Moodley M, Bonorchis
K, Morris V, et al. Antibiotic Stewardship Ward Rounds and a
Dedicated Prescription Chart Reduce Antibiotic Consumption
and Pharmacy Costs without Affecting Inpatient Mortality or
Re-Admission Rates. PLoS ONE [Internet]. 2013 Dec 9 [cited
Nov 6];8(12). Available from: https://www.ncbi.nlm.nih.
gov/pmc/articles/PMC3857167/
Schlesinger Y, Paltiel O, Yinnon AM. Analysis and impact of
infectious disease consultations in a general hospital. J Hosp
Infect 1998;40(1):39–46.
Yim J, Smith JR, Rybak MJ. Role of Combination Antimicrobial
Therapy for Vancomycin-Resistant Enterococcus faecium
Infections: Review of the Current Evidence. Pharmacother J
Hum Pharmacol Drug Ther 2017;37(5):579–92.
Fernando SA, Gray TJ, Gottlieb T. Healthcare-acquired infections:
prevention strategies. Intern Med J 2017;47(12):1341–51.
Cerceo E, Deitelzweig SB, Sherman BM, Amin AN. Multidrug-
Resistant Gram-Negative Bacterial Infections in the Hospital
Setting: Overview, Implications for Clinical Practice, and Emerging
Treatment Options. Microb Drug Resist 2016;22(5):412–31.
Boyanova L, Mitov I. Antibiotic resistance rates in causative
agents of infections in diabetic patients: rising concerns. Expert
Rev Anti Infect Ther 2013(4):411–20.
Falagas ME, Tansarli GS, Karageorgopoulos DE, Vardakas KZ.
Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae
Infections. Emerg Infect Dis 2014;20(7):1170–5.
Ousaid A, Akrim J, Khayati Y. Overuse of antibiotics as a key
driver to antibiotic resistance in Morocco: A short review with
potential solutions. Int Arab J Antimicrob Agents 2020, May 12
[cited 2020 Jun 14];10(1). Available from: http://imed.pub/ojs/
index.php/ IAJAA/ article/view/2368
Hamze M. Epidemiology and Antibiotic Susceptibility Patterns
of Carbapenem Resistant Gram Negative Bacteria Isolated
from Two Tertiary Care Hospitals in North Lebanon. Int Arab
J Antimicrob Agents [Internet]. 2018 Oct 21 [cited 2020 Jun
;8(2). Available from: http://imed.pub/ojs/index.php/IAJAA/
article/view/2333
Jamal S, Al Atrouni A, Rafei R, Dabboussi F, Hamze M, Osman
M. Molecular mechanisms of antimicrobial resistance in
Acinetobacter baumannii, with a special focus on its epidemiology
in Lebanon. J Glob Antimicrob Resist 2018;15:154–63.
Sexton DJ, Corey GR, Ingram CW, Morris VM, Haywood
HB. Consultation in university-based and community-based
infectious disease practices: a prospective study. Clin Infect Dis
Off Publ Infect Dis Soc Am 1995;20(2):391–3.
Downloads
Published
Issue
Section
License
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access and Benefits of Publishing Open Access).
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Articles are published Under License of Creative Commons Attribution 3.0 License ©
Copyright policies & self-archiving
This is our Copyright Policy. We are a RoMEO green journal.
| Author's Pre-print: |  author can archive pre-print (ie pre-refereeing) |
| Author's Post-print: | author can archive post-print (ie final draft post-refereeing) |
| Publisher's Version/PDF: | author can archive publisher's version/PDF |
